Compare PLSE & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | ICHR |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2016 | 2016 |
| Metric | PLSE | ICHR |
|---|---|---|
| Price | $13.86 | $28.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $22.00 | ★ $30.60 |
| AVG Volume (30 Days) | 162.7K | ★ 999.7K |
| Earning Date | 02-19-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $86,000.00 | ★ $957,337,000.00 |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | $1,057.59 | $5.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.86 |
| 52 Week Low | $12.56 | $13.12 |
| 52 Week High | $25.00 | $35.56 |
| Indicator | PLSE | ICHR |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 52.79 |
| Support Level | $13.44 | $27.03 |
| Resistance Level | $15.25 | $32.15 |
| Average True Range (ATR) | 0.80 | 2.33 |
| MACD | -0.00 | -0.66 |
| Stochastic Oscillator | 23.10 | 15.67 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.